Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2002 | 12-2001 | 09-2001 | 06-2001 | 03-2001 | |
| Sales | 4,941 | 4,401 | 5,480 | 5,779 | 6,313 |
| Cost of Goods | 1,259 | 1,162 | 1,274 | 1,885 | 2,188 |
| Gross Profit | 3,682 | 3,239 | 4,206 | 3,894 | 4,125 |
| Operating Expenses | 29,136 | 33,996 | 27,774 | 22,864 | 19,024 |
| Operating Income | -25,195 | -30,595 | -23,294 | -18,085 | -14,711 |
| Interest Expense | 3,022 | 2,527 | 40 | 43 | 47 |
| Other Income | 2,772 | 4,744 | 3,403 | 3,294 | 1,721 |
| Pre-tax Income | -25,445 | -28,378 | -19,931 | -14,834 | -13,037 |
| Net Income Continuous | -25,445 | -28,378 | -19,931 | -14,834 | -13,037 |
| Net Income | $-25,445 | $-28,378 | $-19,931 | $-14,834 | $-13,037 |
| EPS Basic Total Ops | -0.58 | -0.66 | -0.46 | -0.34 | -0.35 |
| EPS Basic Continuous Ops | -0.58 | -0.66 | -0.46 | -0.34 | -0.35 |
| EPS Diluted Total Ops | -0.58 | -0.66 | -0.46 | -0.34 | -0.35 |
| EPS Diluted Continuous Ops | -0.58 | -0.66 | -0.46 | -0.34 | -0.35 |
| EBITDA(a) | $-23,187 | $-28,785 | $-21,775 | $-16,666 | $-13,382 |